These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4711770)

  • 21. EFFECT OF HYPERTONIC MANNITOL INFUSION ON RENAL CLEARANCES IN HUMANS WITH NORMAL OR DISEASED KIDNEYS.
    DOBERNECK RC; MAZZE RI; SCHWARTZ FD; BARRY KG
    J Urol; 1964 Feb; 91():123-6. PubMed ID: 14115895
    [No Abstract]   [Full Text] [Related]  

  • 22. [Protein supply in healthy subjects and subjects with kidney diseases].
    Gerhardt W
    Z Arztl Fortbild (Jena); 1969 Mar; 63(6):317-22. PubMed ID: 5784072
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oral carbenicillin treatment with carindacillin (author's transl)].
    Naumann P; Rosin H
    Dtsch Med Wochenschr; 1973 Nov; 98(46):2200-2 contd. PubMed ID: 4202153
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrin degradation products in renal parenchymal disease states and renal transplant patients.
    Shah BC; Ambrus JL; Mink IB; Albert DJ; Sampson D; Murphy GP
    Transplantation; 1972 Dec; 14(6):705-10. PubMed ID: 4566268
    [No Abstract]   [Full Text] [Related]  

  • 25. [Expression of fibronectin receptor and vitronectin receptor in diseased human kidneys].
    Okada M; Yoshioka K; Takemura T; Murakami K; Maki S
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1139-46. PubMed ID: 7505344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acid-base equilibrium in some juvenile kidney diseases].
    Hradcová L; Raska B
    Cas Lek Cesk; 1967 May; 106(20):532-4. PubMed ID: 6080455
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acid-base metabolism in kdney diseases].
    Kaufmann W; Ilg R
    Dtsch Med Wochenschr; 1968 Dec; 93(52):2520-5. PubMed ID: 5722754
    [No Abstract]   [Full Text] [Related]  

  • 28. Excretion and metabolism of reserpine in renal failure.
    Zsotér TT; Johnson GE; DeVeber GA; Paul H
    Clin Pharmacol Ther; 1973; 14(3):325-30. PubMed ID: 4698561
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of renal tissue levels of antibiotics].
    Naber K; Madsen PO; Bichler KH; Sauerwein D
    Infection; 1973; 1(4):208-13. PubMed ID: 4789546
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetics of carbenicillin in children following intramuscular injection].
    Neussel H; Olbing H
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):444-9. PubMed ID: 5046055
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy in the perinatal stage, with special reference to ampicillin and carbenicillin].
    Saito T
    Jpn J Antibiot; 1972 Oct; 25(5):299-315. PubMed ID: 4539521
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic and clinical studies with carfecillin.
    Graber H; Benesch L; Arr M; Magyar T
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):59-62. PubMed ID: 631972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical importance of the radioimmunologic determination of beta 2-microglobulin in patients with kidney pathology].
    Trusov VV; Filimonov MA; Kazakova IA; Marizin SA
    Ter Arkh; 1988; 60(11):117-20. PubMed ID: 2907187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselective renal secretion of carbenicillin in rabbits: role of the organic anion transporter at the renal brush border membrane.
    Itoh T; Nakaura H; Koyano S; Tsuda Y; Yamada H
    Chirality; 1998; 10(4):349-57. PubMed ID: 9614690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of blood sugar equilibrium in chronic nephropathies].
    Sdrobici D; Mătrescu F; Scridon G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(5):467-72. PubMed ID: 32601
    [No Abstract]   [Full Text] [Related]  

  • 37. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current state of the problem of lipid metabolism in patients with kidney diseases].
    Storozhenko AA
    Klin Med (Mosk); 1973 Oct; 51(10):28-30. PubMed ID: 4787276
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renal magnesium transport in glomerulonephritis and pyelonephritis with special emphasis on the terminal stage].
    Röckel A; Hennemann H; Heidland A
    Klin Wochenschr; 1971 Mar; 49(5):251-5. PubMed ID: 5548252
    [No Abstract]   [Full Text] [Related]  

  • 40. [17-hydroxycorticosteroids and hydrocortisone binding with transcortin in chronic kidney diseases].
    Gerasimova EN; Egorova LI; Dadiani EN; Paleeva FM
    Klin Med (Mosk); 1969 Aug; 47(8):34-9. PubMed ID: 5373408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.